Novexia Pharma Private Limited

Novexia Pharma Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
CIN U74999DL2018PTC339169 Incorporated 20 September 2018 ROC Delhi HQ New Delhi, Delhi, India
Active Private Limited Company pharma MSME · Micro
Data last updated
Revenue · FY 2024
₹35,470
▼ 98% YoY
Net loss · FY 2024
₹11.14 Lakh
Latest filing
EBITDA · FY 2024
-₹11.1 Lakh
Latest filing
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
8 yrs
Est. 2018
Directors on board
3
As per MCA filings
Active GSTINs
2
GST registered

About Novexia Pharma Private Limited

Data last updated:

Novexia Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 20 September 2018 and has been in existence for over 8 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2018PTC339169. Its GSTIN is 07AAGCN2021H1ZU (Delhi). The company holds 2 GST registrations, all of them active.

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Akhilesh Kumar Maurya and Kunwar Anand Singh.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 206 – A 2nd Floor Usha Kiran Building Commercial Complex Naniwala Bagh, New Delhi, Delhi, India – 110033.

As per the financials filed for FY 2024, the company reported a revenue of ₹35,470, a decline of 98% compared to the previous year. For the same year it recorded a net loss of ₹11.14 Lakh and EBITDA of -₹11.1 Lakh. Revenue has declined at a compounded annual rate (CAGR) of 56% over three years.

Novexia Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-06-0022154).

Company details

CIN U74999DL2018PTC339169
Registration Number 339169
Incorporation Date 20 September 2018
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
MSME Classification Micro
Udyam Registration UDYAM-DL-06-0022154
Key People
Akhilesh Kumar Maurya Director Kunwar Anand Singh Director Deepak Kumar Director

Recognitions & Rankings of Novexia Pharma

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-DL-06-0022154

Contact details

Novexia Pharma Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    206 – A 2nd Floor Usha Kiran Building Commercial Complex Naniwala Bagh, New Delhi, Delhi, India – 110033
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Novexia Pharma Private Limited, buy the company report.

Comprehensive company report
Novexia Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Novexia Pharma is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Novexia Pharma Private Limited, buy the company report.

Financials of Novexia Pharma Private Limited

FY 2024 filings available

Novexia Pharma Private Limited reported revenue of ₹35,470 (down 98% YoY) for FY 2024.

Revenue · FY 2024
₹35,470 ▼ 98%
Net loss · FY 2024
₹11.14 Lakh
EBITDA · FY 2024
-₹11.1 Lakh

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 98%
3 years · compounded
▼ 56%
EBITDA CAGR growth
1 year
▼ 108%
3 years · compounded
▼ 174%
5 years · compounded
▼ 114%

Revenue has declined at a compounded annual rate (CAGR) of 56% over three years, including a 98% fall in the latest year. EBITDA fell 108% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹11.1 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹11.14 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin
Net Profit Margin
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Novexia Pharma Private Limited, buy the company report.

Board of directors of Novexia Pharma Private Limited

Novexia Pharma has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Akhilesh Kumar Maurya
Also directs: Helistra Healthcare Private Limited, Neopulse Lifesciences Private Limited
Director07 Jan 20224 Years 9 MonthsCurrent
Kunwar Anand Singh
Also directs: Neopulse Lifesciences Private Limited, Genoviq Lifesciences Private Limited, Genoviq Healthcare Private Limited
Director04 Jan 20242 Years 10 MonthsCurrent
Deepak Kumar
Also directs: Neopulse Lifesciences Private Limited, Genoviq Lifesciences Private Limited, Genoviq Healthcare Private Limited
Director04 Jan 20242 Years 10 MonthsCurrent
View all directors

Peer comparison

Novexia Pharma Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Relife Herbo Health Care Private Limited₹36,587 (FY 2021)New Delhi, Delhi, India
Medicraft Life Science Limited₹35,850 (FY 2019)-22.0%Nagpur, Maharashtra, India
Novexia Pharma Private Limitedthis company₹35,470 (FY 2024)-₹11.14 Lakh-98.0%New Delhi, Delhi, India
RPS Healthcare Private Limited₹35,184 (FY 2020)-99.0%Bangalore, Karnataka, India
Beatus Pharmaceuticals Private Limited₹34,982 (FY 2025)19.0%Lucknow, Uttar Pradesh, India

To see the full peer comparison of Novexia Pharma Private Limited, buy the company report.

Auditor

Novexia Pharma Private Limited is audited by S DHINGRA & COMPANY for the financial year 2023.

Auditor firmFinancial yearFirm registration number
S DHINGRA & COMPANYFY 2023028360N

Shareholding

The shareholding of Novexia Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Novexia Pharma Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Novexia Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Novexia Pharma has 2 GST registrations: 2 active.

Total GSTINs
2
Active
2
GSTINStateStatusRegistered on
07AAGCN2021H1ZUDelhiActive28 Jul 2020
09AAGCN2021H1ZQUttar PradeshActive01 May 2024

To see the full GST registrations and return filing status of Novexia Pharma Private Limited, buy the company report.

Recent activity

Novexia Pharma Private Limited has 8 board changes on record since 2020: 3 appointments and 5 cessations. The latest: Benche Lal ceased to be Director on 08 Jan 2024.

AGM
Novexia Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Novexia Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Ceased
Benche Lal ceased to be Director.
Appointed
Deepak Kumar was appointed as Director.
Appointed
Kunwar Anand Singh was appointed as Director.
Ceased
Vipul Jha ceased to be Additional Director.
Ceased
Akhilesh Kumar Maurya ceased to be Additional Director.
Ceased
Bablu Malik ceased to be Director.
Appointed
Akhilesh Kumar Maurya was appointed as Director.
Ceased
Satya Vir ceased to be Director.
Incorporation
20 Sep 2018
Novexia Pharma Private Limited was registered on 20 Sep 2018 with Roc Delhi & aged 8 years 1 month as per MCA records.

Frequently asked questions

Novexia Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 20 September 2018 (8+ years old) and is registered under CIN U74999DL2018PTC339169.

Novexia Pharma has 3 current directors:

The latest financial statements of Novexia Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2019 are in the company report.

The GSTIN of Novexia Pharma is 07AAGCN2021H1ZU, registered in Delhi. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 09AAGCN2021H1ZQ (Uttar Pradesh).

The CIN (Corporate Identification Number) of Novexia Pharma is U74999DL2018PTC339169. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Novexia Pharma was incorporated on 20 September 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of Novexia Pharma by revenue are Relife Herbo Health Care Private Limited, Medicraft Life Science Limited, RPS Healthcare Private Limited, Beatus Pharmaceuticals Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).

Benche Lal ceased to be Director on 08 Jan 2024. Deepak Kumar was appointed as Director on 04 Jan 2024. Kunwar Anand Singh was appointed as Director on 04 Jan 2024. Novexia Pharma has 8 board changes on record in total.

Yes, Novexia Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-06-0022154).

The registered office of Novexia Pharma is at 206 – A 2nd Floor Usha Kiran Building Commercial Complex Naniwala Bagh, New Delhi, Delhi, India – 110033.

Novexia Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.